Movement disorders associated with neuroleptic treatment.
Neuroleptic-induced movement disorders, or extrapyramidal side effects (EPS), can be classified into acute and tardive syndromes. Among the former are parkinsonism, dystonia, and akathisia. Conventional neuroleptics that have traditionally been used to treat psychiatric disorders are often associated with EPS. The newer atypical antipsychotics provide a more promising treatment strategy for psychiatric disorders and have a lower potential for producing EPS than conventional neuroleptics.
Wirshing
W C
WC
Department of Psychiatry and Biobehavioral Science, University of California at Los Angeles School of Medicine, USA.
D000367:Age Factors; D000368:Aged; D017109:Akathisia, Drug-Induced / Q000209:etiology; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D003704:Dementia / Q000188:drug therapy; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D012307:Risk Factors; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use; D012737:Sex Factors
D014150:Antipsychotic Agents; D018967:Risperidone